Early detection of relapse and early therapeutic intervention: The benefits of Devyser NGS method for chimerism analysis
A better patient care is the final objective for Dr. Helena Devos and the team at Sint Jan’s...
News | May 8, 2023
Devyser winner of Swecare Export Awards 2023News | April 24, 2023
Devyser enters agreement with Thermo Fisher Scientific for commercialization of Devyser’s post-transplant NGS productsNews | March 1, 2023
Devyser launches first IVDR-certified product
Simplify your lab workflow with single-tube NGS library preparation method
As a lab manager, you know the importance of streamlining workflows to maximize productivity and...
New more sensitive diagnostics protect transplanted kidney
With new more sensitive diagnostics, rejection of a transplanted kidney can be detected earlier,...
Early relapse prediction after allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia (ALL) using lineage-specific chimerism analysis
Hematopoietic stem cell transplantation (HSCT) is the only curative treatment for patients with...